 Debashis Ghosh
Concepts (712)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gene Expression Profiling | 52 | 2023 | 1518 | 4.740 |
Why?
| | Data Interpretation, Statistical | 27 | 2020 | 321 | 4.710 |
Why?
| | Models, Statistical | 42 | 2021 | 599 | 4.210 |
Why?
| | Algorithms | 37 | 2023 | 1468 | 3.860 |
Why?
| | Oligonucleotide Array Sequence Analysis | 35 | 2016 | 740 | 3.210 |
Why?
| | Biomarkers, Tumor | 24 | 2022 | 1040 | 2.490 |
Why?
| | Metabolomics | 9 | 2022 | 521 | 2.440 |
Why?
| | Computer Simulation | 33 | 2023 | 872 | 2.370 |
Why?
| | Machine Learning | 8 | 2022 | 316 | 2.330 |
Why?
| | Biometry | 13 | 2011 | 62 | 2.240 |
Why?
| | Neoplasms | 24 | 2022 | 2097 | 1.930 |
Why?
| | Regression Analysis | 13 | 2021 | 944 | 1.550 |
Why?
| | Genomics | 12 | 2024 | 635 | 1.500 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 4 | 2023 | 916 | 1.440 |
Why?
| | Computational Biology | 17 | 2021 | 530 | 1.430 |
Why?
| | Prostatic Neoplasms | 25 | 2012 | 921 | 1.420 |
Why?
| | Neoplasm Proteins | 12 | 2018 | 385 | 1.410 |
Why?
| | Models, Biological | 14 | 2021 | 1620 | 1.400 |
Why?
| | Biomarkers | 14 | 2021 | 3408 | 1.320 |
Why?
| | Gene Expression Regulation, Neoplastic | 22 | 2021 | 1141 | 1.210 |
Why?
| | Causality | 4 | 2022 | 103 | 1.210 |
Why?
| | Statistics, Nonparametric | 8 | 2019 | 385 | 1.210 |
Why?
| | Proportional Hazards Models | 10 | 2022 | 1075 | 1.200 |
Why?
| | Software | 13 | 2022 | 530 | 1.170 |
Why?
| | Biostatistics | 3 | 2014 | 15 | 1.130 |
Why?
| | Humans | 164 | 2024 | 114674 | 1.080 |
Why?
| | Meta-Analysis as Topic | 4 | 2014 | 158 | 0.980 |
Why?
| | Microscopy | 3 | 2023 | 125 | 0.940 |
Why?
| | Magnetoencephalography | 2 | 2021 | 104 | 0.930 |
Why?
| | Colonic Neoplasms | 2 | 2022 | 215 | 0.910 |
Why?
| | Survival Analysis | 11 | 2017 | 1211 | 0.880 |
Why?
| | Lung Neoplasms | 6 | 2022 | 2177 | 0.880 |
Why?
| | Histological Techniques | 1 | 2023 | 40 | 0.870 |
Why?
| | Cognitive Dysfunction | 4 | 2021 | 284 | 0.850 |
Why?
| | Genetic Association Studies | 5 | 2019 | 339 | 0.840 |
Why?
| | Multivariate Analysis | 16 | 2022 | 1430 | 0.830 |
Why?
| | Connectome | 2 | 2021 | 63 | 0.790 |
Why?
| | Mass Spectrometry | 6 | 2022 | 633 | 0.770 |
Why?
| | Parkinsonian Disorders | 1 | 2021 | 28 | 0.760 |
Why?
| | Propensity Score | 4 | 2018 | 224 | 0.740 |
Why?
| | Endpoint Determination | 2 | 2011 | 68 | 0.720 |
Why?
| | Brain Mapping | 2 | 2021 | 524 | 0.720 |
Why?
| | Phenotype | 11 | 2023 | 2796 | 0.720 |
Why?
| | Clinical Trials as Topic | 4 | 2022 | 932 | 0.700 |
Why?
| | Risk Assessment | 8 | 2020 | 2968 | 0.690 |
Why?
| | Image Processing, Computer-Assisted | 7 | 2024 | 683 | 0.680 |
Why?
| | High-Throughput Screening Assays | 2 | 2012 | 123 | 0.680 |
Why?
| | Diagnostic Imaging | 1 | 2022 | 275 | 0.670 |
Why?
| | Learning | 1 | 2023 | 350 | 0.670 |
Why?
| | Models, Genetic | 10 | 2019 | 562 | 0.670 |
Why?
| | Genetic Variation | 4 | 2019 | 870 | 0.660 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2020 | 98 | 0.660 |
Why?
| | Glioma | 1 | 2022 | 294 | 0.640 |
Why?
| | Databases, Factual | 11 | 2020 | 1125 | 0.640 |
Why?
| | DNA Copy Number Variations | 2 | 2017 | 154 | 0.630 |
Why?
| | Quantitative Trait, Heritable | 2 | 2018 | 116 | 0.630 |
Why?
| | Transcriptome | 2 | 2023 | 725 | 0.630 |
Why?
| | Cardiovascular Diseases | 5 | 2022 | 1727 | 0.630 |
Why?
| | Metabolome | 1 | 2021 | 282 | 0.620 |
Why?
| | Randomized Controlled Trials as Topic | 5 | 2021 | 1214 | 0.620 |
Why?
| | Databases, Genetic | 10 | 2021 | 206 | 0.610 |
Why?
| | Logistic Models | 12 | 2020 | 1841 | 0.600 |
Why?
| | Reproducibility of Results | 16 | 2021 | 2763 | 0.580 |
Why?
| | Epidemiologic Methods | 2 | 2007 | 72 | 0.560 |
Why?
| | Immunohistochemistry | 11 | 2022 | 1629 | 0.550 |
Why?
| | Retinol-Binding Proteins | 2 | 2014 | 13 | 0.540 |
Why?
| | Eye Proteins | 3 | 2014 | 70 | 0.530 |
Why?
| | Markov Chains | 7 | 2017 | 114 | 0.510 |
Why?
| | Linear Models | 7 | 2018 | 768 | 0.500 |
Why?
| | Autism Spectrum Disorder | 2 | 2017 | 322 | 0.490 |
Why?
| | Empirical Research | 2 | 2012 | 21 | 0.480 |
Why?
| | Diagnosis, Computer-Assisted | 4 | 2008 | 64 | 0.470 |
Why?
| | Carcinoma, Squamous Cell | 4 | 2017 | 577 | 0.470 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 961 | 0.450 |
Why?
| | Neuroendocrine Tumors | 3 | 2024 | 85 | 0.450 |
Why?
| | Genome-Wide Association Study | 7 | 2018 | 1177 | 0.450 |
Why?
| | Bayes Theorem | 6 | 2012 | 329 | 0.440 |
Why?
| | Protein Tyrosine Phosphatases | 3 | 2019 | 147 | 0.430 |
Why?
| | Disease Progression | 14 | 2021 | 2380 | 0.430 |
Why?
| | Bias | 5 | 2022 | 179 | 0.420 |
Why?
| | Treatment Outcome | 7 | 2021 | 9088 | 0.420 |
Why?
| | Cluster Analysis | 9 | 2023 | 455 | 0.420 |
Why?
| | Tissue Array Analysis | 3 | 2008 | 48 | 0.400 |
Why?
| | Oncogenes | 1 | 2013 | 103 | 0.400 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2022 | 2096 | 0.400 |
Why?
| | Aromatase | 1 | 2012 | 30 | 0.390 |
Why?
| | Male | 59 | 2021 | 55589 | 0.390 |
Why?
| | Sulfhydryl Compounds | 1 | 2014 | 177 | 0.390 |
Why?
| | Alzheimer Disease | 3 | 2015 | 442 | 0.380 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2012 | 108 | 0.380 |
Why?
| | Genome | 5 | 2017 | 271 | 0.380 |
Why?
| | Adenocarcinoma | 4 | 2017 | 795 | 0.370 |
Why?
| | Cardiac Catheterization | 1 | 2015 | 534 | 0.370 |
Why?
| | Liver Neoplasms | 1 | 2015 | 506 | 0.370 |
Why?
| | Polymorphism, Single Nucleotide | 5 | 2019 | 1880 | 0.360 |
Why?
| | Supervised Machine Learning | 2 | 2021 | 11 | 0.350 |
Why?
| | Brain | 3 | 2019 | 2371 | 0.350 |
Why?
| | Antioxidants | 1 | 2014 | 530 | 0.350 |
Why?
| | Gene Expression | 3 | 2014 | 1421 | 0.340 |
Why?
| | Endoplasmic Reticulum | 1 | 2012 | 234 | 0.340 |
Why?
| | Stem Cells | 3 | 2020 | 546 | 0.330 |
Why?
| | Proteomics | 5 | 2009 | 836 | 0.330 |
Why?
| | Nerve Tissue Proteins | 3 | 2020 | 529 | 0.330 |
Why?
| | Tumor Microenvironment | 2 | 2022 | 430 | 0.330 |
Why?
| | Ki-67 Antigen | 2 | 2020 | 103 | 0.330 |
Why?
| | Gene Dosage | 1 | 2010 | 129 | 0.330 |
Why?
| | Epidemiologic Research Design | 1 | 2009 | 27 | 0.330 |
Why?
| | Signal Transduction | 9 | 2023 | 4513 | 0.320 |
Why?
| | Chromatin Immunoprecipitation | 3 | 2017 | 128 | 0.320 |
Why?
| | Sensitivity and Specificity | 10 | 2015 | 1692 | 0.310 |
Why?
| | Bone Marrow Transplantation | 2 | 2008 | 239 | 0.310 |
Why?
| | Carcinoma | 2 | 2007 | 198 | 0.310 |
Why?
| | Protein Array Analysis | 8 | 2009 | 56 | 0.310 |
Why?
| | Emigration and Immigration | 1 | 2008 | 44 | 0.310 |
Why?
| | Racemases and Epimerases | 5 | 2006 | 11 | 0.300 |
Why?
| | DNA-Binding Proteins | 7 | 2018 | 1314 | 0.300 |
Why?
| | Statistical Distributions | 1 | 2008 | 7 | 0.300 |
Why?
| | Probability | 3 | 2021 | 289 | 0.300 |
Why?
| | Arrhythmias, Cardiac | 2 | 2020 | 279 | 0.300 |
Why?
| | Chromosome Mapping | 6 | 2017 | 487 | 0.300 |
Why?
| | Research Design | 5 | 2021 | 928 | 0.300 |
Why?
| | Proteome | 3 | 2007 | 339 | 0.290 |
Why?
| | Flow Cytometry | 2 | 2022 | 1083 | 0.290 |
Why?
| | Aged | 27 | 2022 | 19073 | 0.280 |
Why?
| | Tumor Burden | 1 | 2008 | 259 | 0.280 |
Why?
| | Pancreas | 2 | 2020 | 276 | 0.270 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2021 | 196 | 0.270 |
Why?
| | Female | 42 | 2022 | 59499 | 0.270 |
Why?
| | Diabetes Mellitus | 5 | 2022 | 900 | 0.270 |
Why?
| | Nerve Net | 2 | 2019 | 226 | 0.270 |
Why?
| | Triple Negative Breast Neoplasms | 2 | 2019 | 157 | 0.260 |
Why?
| | Placenta | 1 | 2012 | 626 | 0.260 |
Why?
| | Monte Carlo Method | 4 | 2017 | 138 | 0.260 |
Why?
| | Magnetic Resonance Imaging | 5 | 2022 | 3046 | 0.260 |
Why?
| | Neoplasm Staging | 6 | 2019 | 1167 | 0.260 |
Why?
| | Middle Aged | 29 | 2022 | 26735 | 0.250 |
Why?
| | Cell Proliferation | 5 | 2021 | 2187 | 0.250 |
Why?
| | Cell Nucleus | 2 | 2019 | 554 | 0.250 |
Why?
| | Homeodomain Proteins | 4 | 2020 | 463 | 0.250 |
Why?
| | False Positive Reactions | 4 | 2012 | 109 | 0.240 |
Why?
| | Replication Origin | 1 | 2004 | 15 | 0.240 |
Why?
| | Neoplasm Recurrence, Local | 3 | 2019 | 858 | 0.240 |
Why?
| | ROC Curve | 5 | 2020 | 442 | 0.230 |
Why?
| | Crystallography, X-Ray | 3 | 2019 | 402 | 0.230 |
Why?
| | Data Curation | 1 | 2024 | 11 | 0.230 |
Why?
| | Leukemia | 1 | 2006 | 209 | 0.230 |
Why?
| | Risk Factors | 12 | 2022 | 8632 | 0.230 |
Why?
| | Histones | 4 | 2020 | 535 | 0.230 |
Why?
| | Carrier Proteins | 2 | 2007 | 695 | 0.230 |
Why?
| | Coculture Techniques | 1 | 2004 | 201 | 0.220 |
Why?
| | Breast Neoplasms | 7 | 2014 | 1862 | 0.220 |
Why?
| | Sample Size | 3 | 2008 | 112 | 0.220 |
Why?
| | Lupus Nephritis | 1 | 2023 | 52 | 0.220 |
Why?
| | Statistics as Topic | 2 | 2005 | 292 | 0.220 |
Why?
| | Staining and Labeling | 1 | 2023 | 134 | 0.210 |
Why?
| | Membrane Transport Proteins | 1 | 2004 | 138 | 0.210 |
Why?
| | Common Variable Immunodeficiency | 1 | 2023 | 24 | 0.210 |
Why?
| | Carcinogens | 1 | 2003 | 103 | 0.210 |
Why?
| | Personality | 1 | 2004 | 113 | 0.210 |
Why?
| | Organometallic Compounds | 1 | 2023 | 98 | 0.210 |
Why?
| | Neoplasms, Experimental | 1 | 2003 | 151 | 0.210 |
Why?
| | Tomography, X-Ray Computed | 2 | 2023 | 2285 | 0.210 |
Why?
| | Emphysema | 1 | 2023 | 107 | 0.200 |
Why?
| | Neuroimaging | 2 | 2015 | 249 | 0.200 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 2 | 2019 | 98 | 0.200 |
Why?
| | Head and Neck Neoplasms | 2 | 2017 | 427 | 0.200 |
Why?
| | Promoter Regions, Genetic | 3 | 2009 | 1131 | 0.200 |
Why?
| | Membrane Glycoproteins | 1 | 2004 | 430 | 0.200 |
Why?
| | Artificial Intelligence | 3 | 2008 | 144 | 0.190 |
Why?
| | Brain Waves | 1 | 2021 | 21 | 0.190 |
Why?
| | Epilepsies, Partial | 1 | 2021 | 29 | 0.190 |
Why?
| | Epilepsy | 2 | 2021 | 278 | 0.190 |
Why?
| | Autoantibodies | 5 | 2020 | 1346 | 0.190 |
Why?
| | Anxiety Disorders | 1 | 2004 | 303 | 0.190 |
Why?
| | Adult | 19 | 2022 | 30546 | 0.190 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2023 | 219 | 0.190 |
Why?
| | Genotype | 8 | 2019 | 1760 | 0.180 |
Why?
| | Receptors, Androgen | 2 | 2021 | 131 | 0.180 |
Why?
| | Polymorphism, Genetic | 1 | 2004 | 610 | 0.180 |
Why?
| | Drug Resistant Epilepsy | 1 | 2021 | 45 | 0.180 |
Why?
| | Hyaluronan Receptors | 1 | 2021 | 90 | 0.180 |
Why?
| | Lymphocytes | 2 | 2023 | 330 | 0.180 |
Why?
| | Case-Control Studies | 7 | 2020 | 3003 | 0.180 |
Why?
| | Pulmonary Emphysema | 1 | 2023 | 272 | 0.180 |
Why?
| | Pattern Recognition, Automated | 4 | 2009 | 67 | 0.180 |
Why?
| | Recurrence | 4 | 2010 | 935 | 0.170 |
Why?
| | Precision Medicine | 1 | 2024 | 337 | 0.170 |
Why?
| | Tandem Mass Spectrometry | 3 | 2014 | 411 | 0.170 |
Why?
| | Mexican Americans | 3 | 2008 | 101 | 0.170 |
Why?
| | Prognosis | 11 | 2021 | 3329 | 0.170 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 167 | 0.170 |
Why?
| | Herpes Zoster Vaccine | 1 | 2022 | 159 | 0.170 |
Why?
| | Exome | 2 | 2018 | 200 | 0.170 |
Why?
| | Radiography | 1 | 2022 | 812 | 0.170 |
Why?
| | Tretinoin | 1 | 2020 | 122 | 0.160 |
Why?
| | Pancreatic Neoplasms | 3 | 2019 | 731 | 0.160 |
Why?
| | Gene Expression Regulation | 4 | 2014 | 2320 | 0.160 |
Why?
| | Environmental Exposure | 2 | 2017 | 372 | 0.160 |
Why?
| | Disease | 1 | 2019 | 85 | 0.160 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2019 | 41 | 0.160 |
Why?
| | Bone Regeneration | 1 | 2019 | 21 | 0.160 |
Why?
| | Functional Neuroimaging | 1 | 2019 | 70 | 0.160 |
Why?
| | Small Molecule Libraries | 1 | 2019 | 79 | 0.160 |
Why?
| | Precancerous Conditions | 1 | 2020 | 158 | 0.150 |
Why?
| | SOXB1 Transcription Factors | 1 | 2019 | 60 | 0.150 |
Why?
| | Neoplasms, Second Primary | 1 | 2019 | 92 | 0.150 |
Why?
| | Wilms Tumor | 1 | 2019 | 68 | 0.150 |
Why?
| | Pituitary Gland | 2 | 2009 | 148 | 0.150 |
Why?
| | Genetic Markers | 3 | 2015 | 320 | 0.150 |
Why?
| | Protein Phosphatase 2 | 1 | 2018 | 30 | 0.150 |
Why?
| | Herpes Zoster | 1 | 2022 | 331 | 0.150 |
Why?
| | Observational Studies as Topic | 1 | 2018 | 90 | 0.150 |
Why?
| | Monocytes | 1 | 2020 | 504 | 0.150 |
Why?
| | Lung Diseases, Interstitial | 1 | 2023 | 508 | 0.150 |
Why?
| | RNA, Neoplasm | 1 | 2017 | 80 | 0.150 |
Why?
| | CD24 Antigen | 1 | 2017 | 20 | 0.140 |
Why?
| | DNA Methylation | 3 | 2017 | 495 | 0.140 |
Why?
| | Neoplasm Metastasis | 6 | 2019 | 523 | 0.140 |
Why?
| | Genes, Neoplasm | 3 | 2007 | 20 | 0.140 |
Why?
| | Animals | 18 | 2021 | 31706 | 0.140 |
Why?
| | Transcription, Genetic | 7 | 2013 | 1313 | 0.140 |
Why?
| | Hypoglycemic Agents | 2 | 2021 | 1013 | 0.140 |
Why?
| | Parkinson Disease | 1 | 2021 | 345 | 0.140 |
Why?
| | Clinical Laboratory Techniques | 1 | 2018 | 87 | 0.140 |
Why?
| | Child Health | 1 | 2019 | 127 | 0.140 |
Why?
| | DNA, Neoplasm | 1 | 2017 | 157 | 0.140 |
Why?
| | Peptides | 3 | 2007 | 848 | 0.140 |
Why?
| | Models, Neurological | 1 | 2019 | 212 | 0.140 |
Why?
| | RNA, Messenger | 6 | 2017 | 2553 | 0.140 |
Why?
| | Epigenomics | 1 | 2017 | 101 | 0.140 |
Why?
| | Clinical Trials, Phase III as Topic | 3 | 2012 | 82 | 0.140 |
Why?
| | Analysis of Variance | 3 | 2017 | 1226 | 0.140 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2018 | 115 | 0.140 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2019 | 223 | 0.140 |
Why?
| | Aged, 80 and over | 13 | 2022 | 6347 | 0.140 |
Why?
| | Induction Chemotherapy | 1 | 2017 | 56 | 0.140 |
Why?
| | Osteogenesis | 1 | 2019 | 183 | 0.140 |
Why?
| | Beryllium | 1 | 2018 | 146 | 0.140 |
Why?
| | Up-Regulation | 2 | 2018 | 808 | 0.140 |
Why?
| | Transcription Factors | 6 | 2017 | 1528 | 0.140 |
Why?
| | Principal Component Analysis | 1 | 2017 | 175 | 0.140 |
Why?
| | Tachycardia, Ventricular | 1 | 2018 | 152 | 0.140 |
Why?
| | Chromosome Aberrations | 2 | 2007 | 135 | 0.140 |
Why?
| | Memory, Short-Term | 1 | 2019 | 225 | 0.140 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2019 | 386 | 0.140 |
Why?
| | Lymph Nodes | 1 | 2019 | 419 | 0.140 |
Why?
| | Chemoradiotherapy, Adjuvant | 1 | 2016 | 40 | 0.140 |
Why?
| | RNA, Small Interfering | 1 | 2019 | 535 | 0.140 |
Why?
| | B7-H1 Antigen | 1 | 2018 | 139 | 0.140 |
Why?
| | Mice | 14 | 2021 | 14869 | 0.140 |
Why?
| | Anesthesia Department, Hospital | 1 | 2016 | 1 | 0.140 |
Why?
| | Nurse Anesthetists | 1 | 2016 | 3 | 0.130 |
Why?
| | Anesthesia, Obstetrical | 1 | 2016 | 6 | 0.130 |
Why?
| | Normal Distribution | 2 | 2014 | 19 | 0.130 |
Why?
| | Anus Neoplasms | 1 | 2016 | 24 | 0.130 |
Why?
| | Salivary Gland Neoplasms | 1 | 2016 | 31 | 0.130 |
Why?
| | Air Pollution | 2 | 2017 | 169 | 0.130 |
Why?
| | DNA, Complementary | 3 | 2005 | 256 | 0.130 |
Why?
| | Heart Arrest | 1 | 2020 | 292 | 0.130 |
Why?
| | ErbB Receptors | 2 | 2012 | 554 | 0.130 |
Why?
| | Host-Pathogen Interactions | 1 | 2019 | 295 | 0.130 |
Why?
| | Anesthesiologists | 1 | 2016 | 11 | 0.130 |
Why?
| | Protein Binding | 4 | 2019 | 1890 | 0.130 |
Why?
| | Insulin-Secreting Cells | 1 | 2020 | 317 | 0.130 |
Why?
| | Transcriptional Activation | 1 | 2018 | 337 | 0.130 |
Why?
| | Kaplan-Meier Estimate | 3 | 2017 | 811 | 0.130 |
Why?
| | Analgesia, Obstetrical | 1 | 2016 | 17 | 0.130 |
Why?
| | Gastrointestinal Microbiome | 1 | 2022 | 501 | 0.130 |
Why?
| | Health Services Research | 1 | 2019 | 371 | 0.130 |
Why?
| | Berylliosis | 1 | 2018 | 177 | 0.130 |
Why?
| | Respiratory Sounds | 2 | 2007 | 110 | 0.130 |
Why?
| | Models, Theoretical | 1 | 2020 | 515 | 0.130 |
Why?
| | Cough | 2 | 2007 | 107 | 0.130 |
Why?
| | Atrial Fibrillation | 1 | 2020 | 322 | 0.130 |
Why?
| | HIV Infections | 3 | 2022 | 2469 | 0.130 |
Why?
| | Anal Canal | 1 | 2016 | 84 | 0.130 |
Why?
| | Colorectal Neoplasms | 3 | 2012 | 615 | 0.130 |
Why?
| | Blood Glucose | 2 | 2022 | 1828 | 0.130 |
Why?
| | Cancer Survivors | 1 | 2019 | 205 | 0.130 |
Why?
| | Cell Transformation, Neoplastic | 4 | 2007 | 308 | 0.130 |
Why?
| | Defibrillators, Implantable | 1 | 2018 | 286 | 0.120 |
Why?
| | Cell Differentiation | 2 | 2020 | 1701 | 0.120 |
Why?
| | Tumor Cells, Cultured | 4 | 2021 | 849 | 0.120 |
Why?
| | Kidney Neoplasms | 1 | 2019 | 327 | 0.120 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 329 | 0.120 |
Why?
| | Cell Line, Tumor | 7 | 2019 | 2710 | 0.120 |
Why?
| | Time Factors | 5 | 2016 | 6115 | 0.120 |
Why?
| | Schizophrenia | 1 | 2019 | 414 | 0.120 |
Why?
| | Nuclear Proteins | 1 | 2019 | 591 | 0.120 |
Why?
| | Executive Function | 1 | 2019 | 380 | 0.120 |
Why?
| | Longitudinal Studies | 4 | 2018 | 2387 | 0.120 |
Why?
| | Risk | 1 | 2017 | 812 | 0.120 |
Why?
| | Hypocreales | 1 | 2014 | 8 | 0.120 |
Why?
| | Leishmaniasis, Visceral | 1 | 2014 | 5 | 0.120 |
Why?
| | Survival Rate | 4 | 2019 | 1644 | 0.120 |
Why?
| | Genetic Predisposition to Disease | 4 | 2019 | 2086 | 0.120 |
Why?
| | Influenza Vaccines | 1 | 2019 | 497 | 0.120 |
Why?
| | Discriminant Analysis | 3 | 2020 | 37 | 0.120 |
Why?
| | Ants | 1 | 2014 | 26 | 0.120 |
Why?
| | Metmyoglobin | 1 | 2014 | 2 | 0.110 |
Why?
| | Sulfonic Acids | 1 | 2014 | 12 | 0.110 |
Why?
| | Treatment Failure | 1 | 2015 | 331 | 0.110 |
Why?
| | Chromatography, Ion Exchange | 1 | 2014 | 48 | 0.110 |
Why?
| | Cohort Studies | 8 | 2017 | 4895 | 0.110 |
Why?
| | Benzothiazoles | 1 | 2014 | 32 | 0.110 |
Why?
| | Chromatography, Affinity | 1 | 2014 | 80 | 0.110 |
Why?
| | Chromatography, Gel | 1 | 2014 | 122 | 0.110 |
Why?
| | Free Radical Scavengers | 1 | 2014 | 78 | 0.110 |
Why?
| | Odds Ratio | 3 | 2020 | 953 | 0.110 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2015 | 217 | 0.110 |
Why?
| | Brain Diseases | 1 | 2015 | 125 | 0.110 |
Why?
| | Embryonic Stem Cells | 1 | 2014 | 106 | 0.110 |
Why?
| | Crystallization | 1 | 2014 | 136 | 0.110 |
Why?
| | Influenza, Human | 1 | 2019 | 546 | 0.110 |
Why?
| | Spectrometry, Fluorescence | 1 | 2014 | 157 | 0.110 |
Why?
| | Trans-Activators | 3 | 2020 | 367 | 0.110 |
Why?
| | Estradiol | 2 | 2014 | 455 | 0.110 |
Why?
| | Electronic Health Records | 1 | 2020 | 800 | 0.110 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2021 | 698 | 0.100 |
Why?
| | Positron-Emission Tomography | 2 | 2024 | 259 | 0.100 |
Why?
| | Arthritis, Rheumatoid | 1 | 2020 | 1003 | 0.100 |
Why?
| | Child | 9 | 2023 | 18412 | 0.100 |
Why?
| | Influenza A Virus, H5N1 Subtype | 1 | 2011 | 5 | 0.100 |
Why?
| | Protein Structure, Tertiary | 2 | 2012 | 796 | 0.100 |
Why?
| | Heme | 1 | 2012 | 52 | 0.100 |
Why?
| | Least-Squares Analysis | 2 | 2020 | 70 | 0.100 |
Why?
| | Transcription Factor Pit-1 | 1 | 2011 | 24 | 0.100 |
Why?
| | RNA, Viral | 1 | 2015 | 565 | 0.100 |
Why?
| | Otx Transcription Factors | 1 | 2011 | 10 | 0.100 |
Why?
| | Lung | 2 | 2023 | 3561 | 0.100 |
Why?
| | MicroRNAs | 1 | 2017 | 600 | 0.100 |
Why?
| | Retina | 1 | 2014 | 263 | 0.100 |
Why?
| | Hypopituitarism | 1 | 2011 | 15 | 0.100 |
Why?
| | Motion | 1 | 2012 | 91 | 0.100 |
Why?
| | Brucella suis | 1 | 2011 | 1 | 0.090 |
Why?
| | Brucellosis | 1 | 2011 | 2 | 0.090 |
Why?
| | Regulatory Sequences, Nucleic Acid | 2 | 2017 | 81 | 0.090 |
Why?
| | Age Factors | 3 | 2020 | 2894 | 0.090 |
Why?
| | Mental Disorders | 1 | 2019 | 892 | 0.090 |
Why?
| | Chemoradiotherapy | 3 | 2017 | 188 | 0.090 |
Why?
| | Caspase 2 | 1 | 2011 | 14 | 0.090 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2011 | 80 | 0.090 |
Why?
| | Prostatic Intraepithelial Neoplasia | 2 | 2008 | 12 | 0.090 |
Why?
| | Catalytic Domain | 1 | 2012 | 196 | 0.090 |
Why?
| | Cattle | 1 | 2014 | 920 | 0.090 |
Why?
| | Pediatrics | 1 | 2019 | 979 | 0.090 |
Why?
| | Pharmacogenetics | 1 | 2012 | 149 | 0.090 |
Why?
| | Vaccination | 1 | 2019 | 1204 | 0.090 |
Why?
| | Neoplasm Invasiveness | 4 | 2017 | 442 | 0.090 |
Why?
| | Catalysis | 1 | 2012 | 289 | 0.090 |
Why?
| | Stress Disorders, Post-Traumatic | 2 | 2019 | 758 | 0.090 |
Why?
| | Lipid Bilayers | 1 | 2012 | 99 | 0.090 |
Why?
| | Chemokines | 1 | 2011 | 216 | 0.090 |
Why?
| | Oxidation-Reduction | 1 | 2014 | 923 | 0.090 |
Why?
| | Prevalence | 2 | 2015 | 2251 | 0.090 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2011 | 139 | 0.090 |
Why?
| | Zalcitabine | 1 | 2010 | 2 | 0.090 |
Why?
| | Activities of Daily Living | 2 | 2003 | 349 | 0.090 |
Why?
| | Gene Silencing | 2 | 2007 | 171 | 0.090 |
Why?
| | Didanosine | 1 | 2010 | 13 | 0.090 |
Why?
| | Nonlinear Dynamics | 1 | 2010 | 83 | 0.090 |
Why?
| | Pregnancy | 4 | 2017 | 5518 | 0.080 |
Why?
| | Phosphoglycerate Kinase | 1 | 2009 | 2 | 0.080 |
Why?
| | Antibody Formation | 2 | 2007 | 266 | 0.080 |
Why?
| | Delivery of Health Care | 1 | 2016 | 833 | 0.080 |
Why?
| | Sarcosine | 1 | 2009 | 8 | 0.080 |
Why?
| | Decision Trees | 2 | 2020 | 81 | 0.080 |
Why?
| | Protein Conformation | 1 | 2012 | 805 | 0.080 |
Why?
| | Follow-Up Studies | 4 | 2019 | 4411 | 0.080 |
Why?
| | Anti-HIV Agents | 1 | 2015 | 666 | 0.080 |
Why?
| | Retinitis Pigmentosa | 1 | 2008 | 16 | 0.080 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 2010 | 116 | 0.080 |
Why?
| | Peptide Library | 2 | 2007 | 81 | 0.080 |
Why?
| | Androgens | 2 | 2009 | 167 | 0.080 |
Why?
| | Psoriasis | 1 | 2009 | 74 | 0.080 |
Why?
| | Genes, Recessive | 1 | 2008 | 73 | 0.080 |
Why?
| | Exercise | 1 | 2018 | 1644 | 0.080 |
Why?
| | Homozygote | 1 | 2008 | 187 | 0.080 |
Why?
| | Acculturation | 1 | 2008 | 50 | 0.080 |
Why?
| | Complex Mixtures | 1 | 2007 | 11 | 0.070 |
Why?
| | Respiratory Tract Infections | 1 | 2011 | 319 | 0.070 |
Why?
| | Practice Patterns, Physicians' | 1 | 2016 | 1177 | 0.070 |
Why?
| | Uncertainty | 1 | 2008 | 95 | 0.070 |
Why?
| | Pituitary Neoplasms | 1 | 2009 | 157 | 0.070 |
Why?
| | Glaucoma | 1 | 2010 | 202 | 0.070 |
Why?
| | Proteins | 2 | 2003 | 908 | 0.070 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2007 | 39 | 0.070 |
Why?
| | Mice, Nude | 2 | 2021 | 630 | 0.070 |
Why?
| | Blindness | 1 | 2008 | 37 | 0.070 |
Why?
| | Young Adult | 6 | 2020 | 10466 | 0.070 |
Why?
| | Socioeconomic Factors | 2 | 2008 | 1078 | 0.070 |
Why?
| | Confidence Intervals | 1 | 2008 | 305 | 0.070 |
Why?
| | Lymphatic Metastasis | 2 | 2019 | 275 | 0.070 |
Why?
| | Self Concept | 1 | 2009 | 214 | 0.070 |
Why?
| | Leisure Activities | 1 | 2007 | 25 | 0.070 |
Why?
| | Antibodies, Neoplasm | 1 | 2007 | 30 | 0.070 |
Why?
| | Genome, Human | 4 | 2016 | 347 | 0.070 |
Why?
| | Genes, myc | 1 | 2007 | 46 | 0.070 |
Why?
| | Genome, Bacterial | 2 | 2006 | 106 | 0.070 |
Why?
| | Decision Theory | 1 | 2006 | 1 | 0.070 |
Why?
| | Nails | 1 | 2007 | 8 | 0.070 |
Why?
| | Information Storage and Retrieval | 1 | 2007 | 106 | 0.070 |
Why?
| | Mutation, Missense | 1 | 2008 | 293 | 0.070 |
Why?
| | United States | 7 | 2018 | 12182 | 0.070 |
Why?
| | Arsenic | 1 | 2007 | 37 | 0.070 |
Why?
| | Haemophilus influenzae | 1 | 2006 | 48 | 0.070 |
Why?
| | Haemophilus Infections | 1 | 2006 | 28 | 0.070 |
Why?
| | Serine Endopeptidases | 1 | 2007 | 102 | 0.070 |
Why?
| | Pharynx | 1 | 2006 | 49 | 0.070 |
Why?
| | Genes, MHC Class II | 1 | 2006 | 69 | 0.070 |
Why?
| | DNA, Bacterial | 2 | 2006 | 311 | 0.070 |
Why?
| | Cell Cycle Proteins | 2 | 2007 | 551 | 0.070 |
Why?
| | Apoptosis | 3 | 2021 | 2363 | 0.060 |
Why?
| | Diabetic Retinopathy | 1 | 2008 | 149 | 0.060 |
Why?
| | Death Certificates | 1 | 2006 | 30 | 0.060 |
Why?
| | Quantitative Trait Loci | 1 | 2008 | 305 | 0.060 |
Why?
| | Calibration | 2 | 2022 | 125 | 0.060 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2023 | 687 | 0.060 |
Why?
| | GATA3 Transcription Factor | 1 | 2005 | 24 | 0.060 |
Why?
| | Lipids | 1 | 2009 | 580 | 0.060 |
Why?
| | Body Mass Index | 2 | 2016 | 1958 | 0.060 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2005 | 56 | 0.060 |
Why?
| | Estrogens | 1 | 2008 | 312 | 0.060 |
Why?
| | Environmental Pollutants | 1 | 2007 | 110 | 0.060 |
Why?
| | Disease-Free Survival | 3 | 2017 | 620 | 0.060 |
Why?
| | Environmental Monitoring | 1 | 2007 | 254 | 0.060 |
Why?
| | Carcinoma, Intraductal, Noninfiltrating | 1 | 2005 | 49 | 0.060 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2006 | 352 | 0.060 |
Why?
| | Protein Interaction Mapping | 1 | 2005 | 101 | 0.060 |
Why?
| | Area Under Curve | 2 | 2020 | 274 | 0.060 |
Why?
| | Retinal Rod Photoreceptor Cells | 1 | 2004 | 11 | 0.060 |
Why?
| | Repressor Proteins | 1 | 2007 | 366 | 0.060 |
Why?
| | Linkage Disequilibrium | 1 | 2005 | 245 | 0.060 |
Why?
| | Retinal Cone Photoreceptor Cells | 1 | 2004 | 14 | 0.060 |
Why?
| | Poisson Distribution | 1 | 2004 | 71 | 0.060 |
Why?
| | Sputum | 1 | 2006 | 285 | 0.060 |
Why?
| | Otitis Media | 1 | 2006 | 142 | 0.060 |
Why?
| | Granulomatous Disease, Chronic | 1 | 2004 | 60 | 0.060 |
Why?
| | Macrophages | 1 | 2011 | 1262 | 0.060 |
Why?
| | Culture Techniques | 1 | 2004 | 78 | 0.060 |
Why?
| | Pedigree | 2 | 2019 | 460 | 0.060 |
Why?
| | Genetic Heterogeneity | 1 | 2004 | 48 | 0.060 |
Why?
| | Bacterial Typing Techniques | 1 | 2004 | 40 | 0.060 |
Why?
| | Fluorescent Antibody Technique | 2 | 2020 | 397 | 0.060 |
Why?
| | Gallium Radioisotopes | 1 | 2023 | 12 | 0.060 |
Why?
| | Asthma | 2 | 2007 | 2029 | 0.060 |
Why?
| | Cause of Death | 1 | 2006 | 361 | 0.060 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2009 | 801 | 0.060 |
Why?
| | Immunophenotyping | 2 | 2020 | 274 | 0.060 |
Why?
| | Genetics, Population | 1 | 2005 | 188 | 0.060 |
Why?
| | Polybrominated Biphenyls | 1 | 2003 | 1 | 0.060 |
Why?
| | Personality Inventory | 1 | 2004 | 131 | 0.060 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 1 | 2004 | 72 | 0.060 |
Why?
| | Immunity, Innate | 1 | 2009 | 720 | 0.060 |
Why?
| | Expressed Sequence Tags | 1 | 2003 | 38 | 0.050 |
Why?
| | Signal-To-Noise Ratio | 1 | 2023 | 56 | 0.050 |
Why?
| | Wnt Proteins | 2 | 2020 | 134 | 0.050 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2019 | 439 | 0.050 |
Why?
| | Bile Ducts | 1 | 2003 | 68 | 0.050 |
Why?
| | Biological Specimen Banks | 1 | 2024 | 94 | 0.050 |
Why?
| | Colorado | 2 | 2024 | 4099 | 0.050 |
Why?
| | Hyperplasia | 1 | 2003 | 163 | 0.050 |
Why?
| | Artifacts | 1 | 2023 | 114 | 0.050 |
Why?
| | Breast | 1 | 2003 | 139 | 0.050 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2023 | 127 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2008 | 1019 | 0.050 |
Why?
| | Sarcoma, Ewing | 1 | 2003 | 64 | 0.050 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2023 | 107 | 0.050 |
Why?
| | Calcium Signaling | 1 | 2004 | 217 | 0.050 |
Why?
| | Motor Activity | 1 | 2007 | 640 | 0.050 |
Why?
| | Biguanides | 1 | 2022 | 12 | 0.050 |
Why?
| | Lymphoma, B-Cell | 1 | 2003 | 86 | 0.050 |
Why?
| | Selection Bias | 1 | 2022 | 33 | 0.050 |
Why?
| | Child, Preschool | 3 | 2022 | 9114 | 0.050 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2023 | 132 | 0.050 |
Why?
| | Biomedical Research | 1 | 2008 | 585 | 0.050 |
Why?
| | Epithelial Cells | 2 | 2008 | 951 | 0.050 |
Why?
| | Benchmarking | 1 | 2023 | 161 | 0.050 |
Why?
| | Genes, BRCA2 | 1 | 2002 | 24 | 0.050 |
Why?
| | Genes, BRCA1 | 1 | 2002 | 31 | 0.050 |
Why?
| | Adolescent | 5 | 2020 | 17841 | 0.050 |
Why?
| | Vaccines, Synthetic | 1 | 2022 | 124 | 0.050 |
Why?
| | Mice, Inbred BALB C | 2 | 2019 | 1144 | 0.050 |
Why?
| | Genetic Testing | 1 | 2004 | 379 | 0.050 |
Why?
| | T-Lymphocyte Subsets | 1 | 2023 | 383 | 0.050 |
Why?
| | Entropy | 1 | 2021 | 35 | 0.050 |
Why?
| | Evolution, Molecular | 1 | 2005 | 430 | 0.050 |
Why?
| | Milk, Human | 1 | 2022 | 127 | 0.050 |
Why?
| | Health Care Surveys | 2 | 2016 | 539 | 0.050 |
Why?
| | Citrullination | 1 | 2020 | 12 | 0.050 |
Why?
| | Interleukin-2 | 1 | 2022 | 413 | 0.050 |
Why?
| | Phosphorylation | 2 | 2018 | 1569 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 923 | 0.040 |
Why?
| | Somatostatin-Secreting Cells | 1 | 2020 | 3 | 0.040 |
Why?
| | Quality of Life | 2 | 2009 | 2353 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 493 | 0.040 |
Why?
| | Human Embryonic Stem Cells | 1 | 2020 | 18 | 0.040 |
Why?
| | Citalopram | 1 | 2020 | 27 | 0.040 |
Why?
| | Somatostatin | 1 | 2020 | 52 | 0.040 |
Why?
| | Immunity, Cellular | 1 | 2022 | 248 | 0.040 |
Why?
| | Receptors, Retinoic Acid | 1 | 2020 | 49 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2022 | 485 | 0.040 |
Why?
| | Policy | 1 | 2021 | 137 | 0.040 |
Why?
| | Nutrition Surveys | 1 | 2021 | 224 | 0.040 |
Why?
| | Support Vector Machine | 1 | 2020 | 34 | 0.040 |
Why?
| | Electroencephalography | 1 | 2021 | 362 | 0.040 |
Why?
| | Embryo, Mammalian | 1 | 2020 | 213 | 0.040 |
Why?
| | Immunoblotting | 3 | 2005 | 283 | 0.040 |
Why?
| | International Classification of Diseases | 1 | 2020 | 116 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2023 | 615 | 0.040 |
Why?
| | Allosteric Regulation | 1 | 2019 | 81 | 0.040 |
Why?
| | Cognition Disorders | 1 | 2003 | 476 | 0.040 |
Why?
| | Nanog Homeobox Protein | 1 | 2019 | 11 | 0.040 |
Why?
| | Breast Feeding | 1 | 2022 | 368 | 0.040 |
Why?
| | Polymethyl Methacrylate | 1 | 2019 | 19 | 0.040 |
Why?
| | Binding Sites | 2 | 2017 | 1168 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2020 | 316 | 0.040 |
Why?
| | Epigenesis, Genetic | 2 | 2017 | 520 | 0.040 |
Why?
| | Schizophrenic Psychology | 1 | 2019 | 86 | 0.040 |
Why?
| | Seizures | 1 | 2021 | 340 | 0.040 |
Why?
| | Interferon-gamma | 1 | 2022 | 719 | 0.040 |
Why?
| | SEER Program | 1 | 2019 | 196 | 0.040 |
Why?
| | B-Lymphocytes | 1 | 2023 | 766 | 0.040 |
Why?
| | Virulence | 2 | 2011 | 227 | 0.040 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 225 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2021 | 4408 | 0.040 |
Why?
| | Herpesvirus 3, Human | 1 | 2022 | 378 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2020 | 2570 | 0.040 |
Why?
| | Protein Domains | 1 | 2019 | 207 | 0.040 |
Why?
| | Mice, SCID | 1 | 2019 | 314 | 0.040 |
Why?
| | Prostatic Hyperplasia | 2 | 2008 | 38 | 0.040 |
Why?
| | Autoantigens | 1 | 2020 | 396 | 0.040 |
Why?
| | Adjuvants, Immunologic | 1 | 2019 | 206 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2020 | 477 | 0.040 |
Why?
| | Protein Stability | 1 | 2018 | 157 | 0.040 |
Why?
| | Melanoma | 1 | 2003 | 620 | 0.040 |
Why?
| | National Cancer Institute (U.S.) | 1 | 2017 | 40 | 0.040 |
Why?
| | Databases, Protein | 2 | 2007 | 59 | 0.040 |
Why?
| | Taiwan | 2 | 2007 | 15 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 555 | 0.030 |
Why?
| | Retrospective Studies | 3 | 2020 | 12549 | 0.030 |
Why?
| | Tissue Scaffolds | 1 | 2019 | 179 | 0.030 |
Why?
| | Michigan | 2 | 2007 | 96 | 0.030 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2016 | 8 | 0.030 |
Why?
| | After-Hours Care | 1 | 2016 | 13 | 0.030 |
Why?
| | Radiotherapy, Intensity-Modulated | 1 | 2017 | 124 | 0.030 |
Why?
| | Sterilization, Tubal | 1 | 2016 | 12 | 0.030 |
Why?
| | Survivors | 1 | 2019 | 411 | 0.030 |
Why?
| | Live Birth | 1 | 2016 | 48 | 0.030 |
Why?
| | Platelet Count | 1 | 2016 | 81 | 0.030 |
Why?
| | Cognition | 1 | 2003 | 989 | 0.030 |
Why?
| | Prostate | 2 | 2008 | 156 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2019 | 750 | 0.030 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2017 | 332 | 0.030 |
Why?
| | Family | 1 | 2019 | 589 | 0.030 |
Why?
| | Enhancer of Zeste Homolog 2 Protein | 2 | 2007 | 37 | 0.030 |
Why?
| | Prostate-Specific Antigen | 2 | 2008 | 151 | 0.030 |
Why?
| | Antibodies, Viral | 1 | 2019 | 520 | 0.030 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2016 | 79 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 591 | 0.030 |
Why?
| | Gene Regulatory Networks | 2 | 2007 | 228 | 0.030 |
Why?
| | Particulate Matter | 1 | 2017 | 185 | 0.030 |
Why?
| | Rats | 1 | 2003 | 4958 | 0.030 |
Why?
| | Cholesterol, HDL | 1 | 2016 | 183 | 0.030 |
Why?
| | Occupational Exposure | 1 | 2018 | 255 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 2011 | 993 | 0.030 |
Why?
| | Cell Movement | 1 | 2019 | 869 | 0.030 |
Why?
| | Genes, Bacterial | 2 | 2006 | 157 | 0.030 |
Why?
| | Neuropsychological Tests | 1 | 2019 | 927 | 0.030 |
Why?
| | Polycomb Repressive Complex 2 | 2 | 2007 | 59 | 0.030 |
Why?
| | Cesarean Section | 1 | 2016 | 169 | 0.030 |
Why?
| | Bangladesh | 1 | 2014 | 31 | 0.030 |
Why?
| | Epistasis, Genetic | 1 | 2015 | 67 | 0.030 |
Why?
| | Cardiovascular System | 1 | 2016 | 125 | 0.030 |
Why?
| | Models, Molecular | 1 | 2019 | 1369 | 0.030 |
Why?
| | Genes, Essential | 1 | 2014 | 18 | 0.030 |
Why?
| | GATA1 Transcription Factor | 1 | 2014 | 13 | 0.030 |
Why?
| | Data Collection | 2 | 2007 | 620 | 0.030 |
Why?
| | Molecular Sequence Annotation | 1 | 2014 | 81 | 0.030 |
Why?
| | Pilot Projects | 1 | 2018 | 1373 | 0.030 |
Why?
| | CpG Islands | 1 | 2014 | 117 | 0.030 |
Why?
| | Receptors, Estrogen | 2 | 2007 | 372 | 0.030 |
Why?
| | North America | 1 | 2014 | 256 | 0.030 |
Why?
| | Methylation | 1 | 2014 | 208 | 0.030 |
Why?
| | Organ Specificity | 1 | 2014 | 268 | 0.030 |
Why?
| | Host-Parasite Interactions | 1 | 2014 | 94 | 0.030 |
Why?
| | Schizosaccharomyces | 1 | 2013 | 53 | 0.030 |
Why?
| | Cell Line | 2 | 2009 | 2637 | 0.030 |
Why?
| | Gene-Environment Interaction | 1 | 2014 | 183 | 0.030 |
Why?
| | Species Specificity | 1 | 2014 | 542 | 0.030 |
Why?
| | Pandemics | 1 | 2021 | 1317 | 0.030 |
Why?
| | Cytokines | 1 | 2020 | 1841 | 0.030 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2013 | 82 | 0.030 |
Why?
| | Sequence Analysis, DNA | 2 | 2006 | 723 | 0.030 |
Why?
| | Databases, Nucleic Acid | 1 | 2012 | 31 | 0.020 |
Why?
| | Prospective Studies | 3 | 2009 | 6219 | 0.020 |
Why?
| | Carboplatin | 1 | 2012 | 135 | 0.020 |
Why?
| | Cetuximab | 1 | 2012 | 90 | 0.020 |
Why?
| | Hospitalization | 1 | 2020 | 1752 | 0.020 |
Why?
| | Paclitaxel | 1 | 2012 | 190 | 0.020 |
Why?
| | Mass Screening | 1 | 2018 | 1004 | 0.020 |
Why?
| | Depression | 1 | 2019 | 1134 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2020 | 4694 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2011 | 292 | 0.020 |
Why?
| | Quinazolines | 1 | 2012 | 240 | 0.020 |
Why?
| | Insulin | 1 | 2020 | 2079 | 0.020 |
Why?
| | Blood Pressure | 1 | 2016 | 1538 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 1355 | 0.020 |
Why?
| | Infant | 1 | 2022 | 7961 | 0.020 |
Why?
| | Cell Death | 1 | 2011 | 323 | 0.020 |
Why?
| | Electrophoresis | 1 | 2009 | 26 | 0.020 |
Why?
| | Pituitary Hormones | 1 | 2009 | 16 | 0.020 |
Why?
| | Sarcosine Dehydrogenase | 1 | 2009 | 1 | 0.020 |
Why?
| | Glycine N-Methyltransferase | 1 | 2009 | 3 | 0.020 |
Why?
| | Bone Morphogenetic Protein Receptors, Type I | 1 | 2009 | 10 | 0.020 |
Why?
| | Antineoplastic Agents | 2 | 2012 | 1879 | 0.020 |
Why?
| | Ophthalmoscopy | 1 | 2008 | 30 | 0.020 |
Why?
| | Electroretinography | 1 | 2008 | 40 | 0.020 |
Why?
| | Consanguinity | 1 | 2008 | 46 | 0.020 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2011 | 285 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2011 | 370 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2009 | 271 | 0.020 |
Why?
| | Gene Library | 1 | 2009 | 114 | 0.020 |
Why?
| | Golgi Apparatus | 1 | 2008 | 89 | 0.020 |
Why?
| | Registries | 1 | 2016 | 1768 | 0.020 |
Why?
| | Chemical Fractionation | 1 | 2007 | 28 | 0.020 |
Why?
| | Genes | 1 | 2008 | 223 | 0.020 |
Why?
| | Keratinocytes | 1 | 2009 | 216 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2009 | 299 | 0.020 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2012 | 663 | 0.020 |
Why?
| | Chromosomes, Human, 16-18 | 1 | 2007 | 4 | 0.020 |
Why?
| | Chromosomes, Human, 6-12 and X | 1 | 2007 | 5 | 0.020 |
Why?
| | Tomography, Optical Coherence | 1 | 2008 | 130 | 0.020 |
Why?
| | Polycomb-Group Proteins | 1 | 2007 | 29 | 0.020 |
Why?
| | Feedback | 1 | 2008 | 144 | 0.020 |
Why?
| | Chromosomes, Human, Pair 5 | 1 | 2007 | 24 | 0.020 |
Why?
| | Chromosomes, Human, Pair 3 | 1 | 2007 | 49 | 0.020 |
Why?
| | DNA Primers | 1 | 2008 | 510 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2013 | 1076 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 4622 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2009 | 347 | 0.020 |
Why?
| | Bacteriophage T7 | 1 | 2007 | 3 | 0.020 |
Why?
| | Neoplasm Transplantation | 1 | 2007 | 228 | 0.020 |
Why?
| | Seaweed | 1 | 2007 | 2 | 0.020 |
Why?
| | Agaricales | 1 | 2007 | 3 | 0.020 |
Why?
| | Models, Animal | 1 | 2009 | 344 | 0.020 |
Why?
| | Lymphoma | 1 | 2008 | 177 | 0.020 |
Why?
| | Data Display | 1 | 2007 | 19 | 0.020 |
Why?
| | Subtraction Technique | 1 | 2007 | 24 | 0.020 |
Why?
| | Seafood | 1 | 2007 | 16 | 0.020 |
Why?
| | Autophagy-Related Proteins | 1 | 2007 | 39 | 0.020 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2013 | 959 | 0.020 |
Why?
| | Chromosomes, Human | 1 | 2007 | 39 | 0.020 |
Why?
| | Oryza | 1 | 2007 | 20 | 0.020 |
Why?
| | Food Contamination | 1 | 2007 | 43 | 0.020 |
Why?
| | Sequence Analysis, Protein | 1 | 2006 | 27 | 0.020 |
Why?
| | Television | 1 | 2007 | 72 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2007 | 197 | 0.020 |
Why?
| | Inhibitory Concentration 50 | 1 | 2006 | 74 | 0.020 |
Why?
| | Fishes | 1 | 2007 | 80 | 0.020 |
Why?
| | Water Supply | 1 | 2007 | 70 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2009 | 444 | 0.020 |
Why?
| | Managed Care Programs | 1 | 2007 | 133 | 0.020 |
Why?
| | Nucleic Acid Hybridization | 1 | 2006 | 187 | 0.020 |
Why?
| | Urban Health | 1 | 2006 | 73 | 0.020 |
Why?
| | Ear, Middle | 1 | 2006 | 89 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2009 | 1230 | 0.020 |
Why?
| | Drug Design | 1 | 2007 | 148 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2011 | 1140 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2012 | 1262 | 0.020 |
Why?
| | Fibrocystic Breast Disease | 1 | 2005 | 2 | 0.020 |
Why?
| | E2F Transcription Factors | 1 | 2005 | 55 | 0.020 |
Why?
| | Databases as Topic | 1 | 2005 | 63 | 0.020 |
Why?
| | Base Composition | 1 | 2005 | 75 | 0.020 |
Why?
| | Housing | 1 | 2006 | 114 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2007 | 329 | 0.020 |
Why?
| | Oligonucleotide Probes | 1 | 2005 | 54 | 0.020 |
Why?
| | DNA Probes | 1 | 2005 | 59 | 0.020 |
Why?
| | Skin | 1 | 2009 | 655 | 0.020 |
Why?
| | Bone Morphogenetic Protein Receptors | 1 | 2004 | 4 | 0.010 |
Why?
| | Neoplasms, Hormone-Dependent | 1 | 2004 | 38 | 0.010 |
Why?
| | Autopsy | 1 | 2004 | 84 | 0.010 |
Why?
| | Receptors, Growth Factor | 1 | 2004 | 49 | 0.010 |
Why?
| | Smad Proteins | 1 | 2004 | 39 | 0.010 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2004 | 39 | 0.010 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2007 | 367 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 2005 | 176 | 0.010 |
Why?
| | Random Allocation | 1 | 2005 | 335 | 0.010 |
Why?
| | Oligonucleotides | 1 | 2004 | 137 | 0.010 |
Why?
| | Retinal Diseases | 1 | 2004 | 76 | 0.010 |
Why?
| | Receptors, Progesterone | 1 | 2005 | 319 | 0.010 |
Why?
| | Overweight | 1 | 2007 | 471 | 0.010 |
Why?
| | Selection, Genetic | 1 | 2005 | 242 | 0.010 |
Why?
| | Spermine | 1 | 2002 | 26 | 0.010 |
Why?
| | Internet | 1 | 2007 | 596 | 0.010 |
Why?
| | Spermidine | 1 | 2002 | 17 | 0.010 |
Why?
| | Adenosine Monophosphate | 1 | 2002 | 49 | 0.010 |
Why?
| | California | 1 | 2003 | 353 | 0.010 |
Why?
| | Cell Cycle | 1 | 2004 | 542 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 797 | 0.010 |
Why?
| | Mental Recall | 1 | 2003 | 171 | 0.010 |
Why?
| | Mutation | 1 | 2012 | 3346 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2006 | 2785 | 0.010 |
Why?
| | Biopsy, Needle | 1 | 2002 | 182 | 0.010 |
Why?
| | Comorbidity | 1 | 2006 | 1448 | 0.010 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2003 | 482 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 2006 | 736 | 0.010 |
Why?
| | Proto-Oncogene Proteins | 1 | 2004 | 608 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2009 | 3535 | 0.010 |
Why?
| | RNA | 1 | 2005 | 809 | 0.010 |
Why?
| | Stroke | 1 | 2003 | 1022 | 0.010 |
Why?
| | Aging | 1 | 2003 | 1618 | 0.010 |
Why?
|
|
Ghosh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|